Announced Thu, 9 Jul · 17:43 IST
Ortin Global clarifies NSE query on segment reporting for FY26
Results View source PDF
ORTINGLOBE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹16.36
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.2-2.3-5.4-2.8-5.3-8.4————
Up moveDown movePending
AI summary
NSE sought clarification on segment details in Ortin Global's Q4 and FY ending 31 March 2026 financial results. The company replied that segment reporting is not applicable as it operates in only one segment: Drugs and Medicines. This is a routine procedural clarification and does not change the reported financials.
Likely market impact
Routine procedural clarification. No material impact on financials or operations.